The Liver Meeting 2020-Postgraduate Course - Part 2 Paradigm Shifts in Hepatology: Rethinking Conventional Wisdom

Postgraduate Course - Part 2 Paradigm Shifts in Hepatology: Rethinking Conventional Wisdom

Video Transcription

Video Summary

Treatment of portal vein thrombosis in cirrhotic patients involves individualized care based on factors like thrombosis extent, symptoms, and transplant status. Consideration of risks and benefits of anticoagulation is crucial, with monitoring for clinical improvement being essential. Addressing contributing factors like protein C deficiency is necessary. Collaboration between medical and interventional approaches is effective in management.<br /><br />Hepatitis C treatment advancements have led to high cure rates, but public health challenges remain for its elimination. Continued surveillance, monitoring post-treatment liver health, and implementing screening protocols are key. To reach WHO's elimination goals by 2030, improving medical practices, blood safety, and treatment access is vital. Successful programs in regions like Egypt have shown significant reductions in hepatitis C cases, while in the US, rising mortality rates pose challenges. Strategies like expanded testing, harm reduction services, and vaccination are crucial in the fight against hepatitis C. Advancements in hepatitis B treatment and considerations for liver disease patients during the COVID-19 pandemic are also highlighted.<br /><br />Investing in public health programs and innovative tools is essential to eliminate hepatitis globally and address the impact of COVID-19 on liver health.

Keywords

portal vein thrombosis

cirrhotic patients

anticoagulation

thrombosis extent

transplant status

protein C deficiency

medical intervention

Hepatitis C treatment

cure rates

public health challenges

WHO elimination goals

blood safety

screening protocols

hepatitis B treatment

COVID-19 pandemic